Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts

The simultaneous increase of computational power and the availability of chemical and biological data have contributed to the recent popularity of in silico bioactivity prediction algorithms. Such methods are commonly used to infer the ‘Mechanism of Action’ of small molecules and they can also be employed in cases where full bioactivity profiles have not been established experimentally. However, protein target predictions by themselves do not necessarily capture information about the effect of a compound on a biological system, and hence merging their output with a systems biology approach can help to better understand the complex network modulation which leads to a particular phenotype. In this work, we review approaches and applications of target prediction, as well as their shortcomings, and demonstrate two extensions of this concept which are exemplified using phenotypic readouts from a chemical genetic screen in Xenopus laevis. In particular, the experimental observations are linked to their predicted bioactivity profiles. Predicted targets are annotated with pathways, which lead to further biological insight. Moreover, we subject the prediction to further machine learning algorithms, namely decision trees, to capture the differential pharmacology of ligand‐target interactions in biological systems. Both methodologies hence provide new insight into understanding the Mechanism of Action of compound activities from phenotypic screens.

[1]  R. Glen,et al.  Diversity Selection of Compounds Based on ‘Protein Affinity Fingerprints’ Improves Sampling of Bioactive Chemical Space , 2013, Chemical biology & drug design.

[2]  Andreas Bender,et al.  In Silico Target Predictions: Defining a Benchmarking Data Set and Comparison of Performance of the Multiclass Naïve Bayes and Parzen-Rosenblatt Window , 2013, J. Chem. Inf. Model..

[3]  J. Medina-Franco,et al.  Shifting from the single to the multitarget paradigm in drug discovery. , 2013, Drug discovery today.

[4]  U. Eggert The why and how of phenotypic small-molecule screens. , 2013, Nature chemical biology.

[5]  P. Clemons,et al.  Target identification and mechanism of action in chemical biology and drug discovery. , 2013, Nature chemical biology.

[6]  Isidro Cortes-Ciriano,et al.  Experimental validation of in silico target predictions on synergistic protein targets , 2013, Journal of Cheminformatics.

[7]  I. Aliagas,et al.  Physicochemical and DMPK in silico models: facilitating their use by medicinal chemists. , 2013, Molecular pharmaceutics.

[8]  Andreas Bender,et al.  Chemogenomics Approaches to Rationalizing the Mode-of-Action of Traditional Chinese and Ayurvedic Medicines , 2013, J. Chem. Inf. Model..

[9]  Dermot F McGinnity,et al.  Application of in silico, in vitro and preclinical pharmacokinetic data for the effective and efficient prediction of human pharmacokinetics. , 2013, Molecular pharmaceutics.

[10]  Julio E. Peironcely,et al.  How Do Metabolites Differ from Their Parent Molecules and How Are They Excreted? , 2013, J. Chem. Inf. Model..

[11]  Dennis A. Smith,et al.  Evolution of ADME science: where else can modeling and simulation contribute? , 2013, Molecular pharmaceutics.

[12]  Maria F. Sassano,et al.  Automated design of ligands to polypharmacological profiles , 2012, Nature.

[13]  R. Glen,et al.  Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism. , 2012, Current pharmaceutical design.

[14]  P. Bork,et al.  Drug discovery in the age of systems biology: the rise of computational approaches for data integration. , 2012, Current opinion in biotechnology.

[15]  A. Laties,et al.  Cystic fibrosis transmembrane conductance regulator contributes to reacidification of alkalinized lysosomes in RPE cells. , 2012, American journal of physiology. Cell physiology.

[16]  M. Gilson,et al.  Public domain databases for medicinal chemistry. , 2012, Journal of medicinal chemistry.

[17]  J. Medina-Franco,et al.  Expanding the medicinally relevant chemical space with compound libraries. , 2012, Drug discovery today.

[18]  Sean Ekins,et al.  Towards a gold standard: regarding quality in public domain chemistry databases and approaches to improving the situation. , 2012, Drug discovery today.

[19]  Jeremy L Jenkins,et al.  Large‐Scale QSAR in Target Prediction and Phenotypic HTS Assessment , 2012, Molecular informatics.

[20]  Bo-Han Su,et al.  Predictive Toxicology Modeling: Protocols for Exploring hERG Classification and Tetrahymena pyriformis End Point Predictions , 2012, J. Chem. Inf. Model..

[21]  Vassilios Ioannidis,et al.  ExPASy: SIB bioinformatics resource portal , 2012, Nucleic Acids Res..

[22]  Igor I. Baskin,et al.  Machine Learning Methods for Property Prediction in Chemoinformatics: Quo Vadis? , 2012, J. Chem. Inf. Model..

[23]  Jeffrey Aubé,et al.  Drug repurposing and the medicinal chemist. , 2012, ACS medicinal chemistry letters.

[24]  Ryan G. Coleman,et al.  ZINC: A Free Tool to Discover Chemistry for Biology , 2012, J. Chem. Inf. Model..

[25]  Guixia Liu,et al.  Performance Evaluation of 2D Fingerprint and 3D Shape Similarity Methods in Virtual Screening , 2012, J. Chem. Inf. Model..

[26]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[27]  Andreas Bender,et al.  Recognizing Pitfalls in Virtual Screening: A Critical Review , 2012, J. Chem. Inf. Model..

[28]  Pekka Tiikkainen,et al.  Analysis of Commercial and Public Bioactivity Databases , 2012, J. Chem. Inf. Model..

[29]  John B. O. Mitchell,et al.  Predicting the mechanism of phospholipidosis , 2012, Journal of Cheminformatics.

[30]  Evan Bolton,et al.  PubChem's BioAssay Database , 2011, Nucleic Acids Res..

[31]  Andreas Bender,et al.  From in silico target prediction to multi-target drug design: current databases, methods and applications. , 2011, Journal of proteomics.

[32]  Jürgen Bajorath,et al.  Assessing the Confidence Level of Public Domain Compound Activity Data and the Impact of Alternative Potency Measurements on SAR Analysis , 2011, J. Chem. Inf. Model..

[33]  Chris Morley,et al.  Open Babel: An open chemical toolbox , 2011, J. Cheminformatics.

[34]  Sean Ekins,et al.  A quality alert and call for improved curation of public chemistry databases. , 2011, Drug discovery today.

[35]  Peter Murray-Rust,et al.  Minimum information about a bioactive entity (MIABE) , 2011, Nature Reviews Drug Discovery.

[36]  Gisbert Schneider,et al.  From Hits to Leads: Challenges for the Next Phase of Machine Learning in Medicinal Chemistry , 2011, Molecular informatics.

[37]  C. Jessus,et al.  Unfertilized Xenopus Eggs Die by Bad-Dependent Apoptosis under the Control of Cdk1 and JNK , 2011, PloS one.

[38]  M. Baccarini,et al.  Raf kinases in cancer–roles and therapeutic opportunities , 2011, Oncogene.

[39]  Meir Glick,et al.  The role of computational methods in the identification of bioactive compounds. , 2011, Current opinion in chemical biology.

[40]  George Karypis,et al.  Improved machine learning models for predicting selective compounds , 2011, BCB '11.

[41]  M. Vikkula,et al.  KITLG mutations cause familial progressive hyper- and hypopigmentation. , 2011, The Journal of investigative dermatology.

[42]  J. Arrowsmith Trial watch: Phase II failures: 2008–2010 , 2011, Nature Reviews Drug Discovery.

[43]  Sean Ekins,et al.  In silico repositioning of approved drugs for rare and neglected diseases. , 2011, Drug discovery today.

[44]  D. Becker,et al.  Expression analysis and molecular targeting of cyclin-dependent kinases in advanced melanoma , 2011, Cell cycle.

[45]  Tudor I. Oprea,et al.  Associating Drugs, Targets and Clinical Outcomes into an Integrated Network Affords a New Platform for Computer‐Aided Drug Repurposing , 2011, Molecular informatics.

[46]  Charles Y. Lin,et al.  DHODH modulates transcriptional elongation in the neural crest and melanoma , 2011, Nature.

[47]  Alexander Statnikov,et al.  Assessing quality and completeness of human transcriptional regulatory pathways on a genome-wide scale , 2011, Biology Direct.

[48]  Jian Xu,et al.  α- and β-adrenoceptors of zebrafish in melanosome movement: a comparative study between embryo and adult melanophores. , 2011, Biochemical and biophysical research communications.

[49]  R. Winklbauer,et al.  PDGF-A controls mesoderm cell orientation and radial intercalation during Xenopus gastrulation , 2011, Development.

[50]  J. Arrowsmith Trial watch: Phase III and submission failures: 2007–2010 , 2011, Nature Reviews Drug Discovery.

[51]  L Zhang,et al.  Applications of Physiologically Based Pharmacokinetic (PBPK) Modeling and Simulation During Regulatory Review , 2011, Clinical pharmacology and therapeutics.

[52]  S. Eaton,et al.  Megalin-dependent Yellow endocytosis restricts melanization in the Drosophila cuticle , 2011, Development.

[53]  David S. Wishart,et al.  DrugBank 3.0: a comprehensive resource for ‘Omics’ research on drugs , 2010, Nucleic Acids Res..

[54]  M. Cisternino,et al.  Noonan syndrome associated with both a new Jnk‐activating familial SOS1 and a de novo RAF1 mutations , 2010, American journal of medical genetics. Part A.

[55]  Antony J. Williams,et al.  ChemSpider:: An Online Chemical Information Resource , 2010 .

[56]  Alexander Tropsha,et al.  Trust, But Verify: On the Importance of Chemical Structure Curation in Cheminformatics and QSAR Modeling Research , 2010, J. Chem. Inf. Model..

[57]  J. Mestres,et al.  In Silico Receptorome Screening of Antipsychotic Drugs , 2010, Molecular informatics.

[58]  Yoshihiro Yamanishi,et al.  Drug-target interaction prediction from chemical, genomic and pharmacological data in an integrated framework , 2010, Bioinform..

[59]  J. McGrath,et al.  The molecular skin pathology of familial primary localized cutaneous amyloidosis , 2010, Experimental dermatology.

[60]  Matt T Bianchi,et al.  Targeting ligand-gated ion channels in neurology and psychiatry: is pharmacological promiscuity an obstacle or an opportunity? , 2010, BMC pharmacology.

[61]  Sean Ekins,et al.  Troubleshooting computational methods in drug discovery. , 2010, Journal of pharmacological and toxicological methods.

[62]  B. Wall,et al.  AKT2 is a downstream target of metabotropic glutamate receptor 1 (Grm1) , 2010, Pigment cell & melanoma research.

[63]  L. Zon,et al.  Melanocytes in development and cancer , 2010, Journal of cellular physiology.

[64]  Ian H. Witten,et al.  The WEKA data mining software: an update , 2009, SKDD.

[65]  Jürgen Bajorath,et al.  From Structure–Activity to Structure–Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds , 2009, ChemMedChem.

[66]  Benjamin E. Deverman,et al.  Cytokines and CNS Development , 2009, Neuron.

[67]  Y. Nishimura,et al.  Zebrafish beta-adrenergic receptor mRNA expression and control of pigmentation. , 2009, Gene.

[68]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[69]  Antti Tanskanen,et al.  11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study) , 2009, The Lancet.

[70]  Sorel Muresan,et al.  Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds , 2009, J. Cheminformatics.

[71]  John A. Tallarico,et al.  Multi-parameter phenotypic profiling: using cellular effects to characterize small-molecule compounds , 2009, Nature Reviews Drug Discovery.

[72]  G. Wheeler,et al.  Chemical genomics identifies compounds affecting Xenopus laevis pigment cell development. , 2009, Molecular bioSystems.

[73]  P. Guan,et al.  A chemical genomic approach identifies matrix metalloproteinases as playing an essential and specific role in Xenopus melanophore migration. , 2009, Chemistry & biology.

[74]  Bin Chen,et al.  Gaining Insight into Off-Target Mediated Effects of Drug Candidates with a Comprehensive Systems Chemical Biology Analysis , 2009, J. Chem. Inf. Model..

[75]  Andreas Bender,et al.  How Similar Are Similarity Searching Methods? A Principal Component Analysis of Molecular Descriptor Space , 2009, J. Chem. Inf. Model..

[76]  Andreas Bender,et al.  Ligand-Target Prediction Using Winnow and Naive Bayesian Algorithms and the Implications of Overall Performance Statistics , 2008, J. Chem. Inf. Model..

[77]  A. Hopkins Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[78]  R. Solé,et al.  Data completeness—the Achilles heel of drug-target networks , 2008, Nature Biotechnology.

[79]  J. Lehár,et al.  High-order combination effects and biological robustness , 2008, Molecular systems biology.

[80]  Tudor I. Oprea,et al.  WOMBAT and WOMBAT‐PK: Bioactivity Databases for Lead and Drug Discovery , 2008 .

[81]  J. Qu,et al.  [Expression of dopamine receptor D2 and adenosine receptor A2A in human retinal pigment epithelium]. , 2007, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[82]  Yoichi Matsubara,et al.  Cardio-facio-cutaneous and Noonan syndromes due to mutations in the RAS/MAPK signalling pathway: genotype–phenotype relationships and overlap with Costello syndrome , 2007, Journal of Medical Genetics.

[83]  T. Ban Fifty years chlorpromazine: a historical perspective , 2007, Neuropsychiatric disease and treatment.

[84]  Michael J Ackerman,et al.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy , 2007, Nature Genetics.

[85]  Bin Zhou,et al.  Large-Scale Annotation of Small-Molecule Libraries Using Public Databases , 2007, J. Chem. Inf. Model..

[86]  A. Bender,et al.  Analysis of Pharmacology Data and the Prediction of Adverse Drug Reactions and Off‐Target Effects from Chemical Structure , 2007, ChemMedChem.

[87]  O. Rath,et al.  MAP kinase signalling pathways in cancer , 2007, Oncogene.

[88]  ヨッヘン クロック,et al.  The use of opioid receptor antagonists , 2007 .

[89]  R. Scolyer,et al.  Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma , 2007, Modern Pathology.

[90]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[91]  Tudor I. Oprea,et al.  Target, chemical and bioactivity databases – integration is key , 2006 .

[92]  R. Snyder,et al.  Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database. , 2006, Pharmacogenomics.

[93]  Z. Deng,et al.  Bridging chemical and biological space: "target fishing" using 2D and 3D molecular descriptors. , 2006, Journal of medicinal chemistry.

[94]  Monya Baker,et al.  Open-access chemistry databases evolving slowly but not surely , 2006, Nature Reviews Drug Discovery.

[95]  M. Pittelkow,et al.  Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. , 2006, The Journal of investigative dermatology.

[96]  Jürgen Drews,et al.  Case histories, magic bullets and the state of drug discovery , 2006, Nature Reviews Drug Discovery.

[97]  Richard Morphy,et al.  The physicochemical challenges of designing multiple ligands. , 2006, Journal of medicinal chemistry.

[98]  G. V. Paolini,et al.  Global mapping of pharmacological space , 2006, Nature Biotechnology.

[99]  William Lingran Chen,et al.  Chemoinformatics: Past, Present, and Future† , 2006, J. Chem. Inf. Model..

[100]  S. Aspengren,et al.  Studies of pigment transfer between Xenopus laevis melanophores and fibroblasts in vitro and in vivo. , 2006, Pigment cell research.

[101]  John P. Overington,et al.  Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.

[102]  Alexander E. Kel,et al.  TRANSPATH®: an information resource for storing and visualizing signaling pathways and their pathological aberrations , 2005, Nucleic Acids Res..

[103]  Alexander E. Kel,et al.  TRANSFAC® and its module TRANSCompel®: transcriptional gene regulation in eukaryotes , 2005, Nucleic Acids Res..

[104]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[105]  Katsuaki Sato,et al.  Carbonic Anhydrase II Is a Tumor Vessel Endothelium–Associated Antigen Targeted by Dendritic Cell Therapy , 2005, Clinical Cancer Research.

[106]  R. Morphy,et al.  Designed multiple ligands. An emerging drug discovery paradigm. , 2005, Journal of medicinal chemistry.

[107]  M. Klagsbrun,et al.  A role for axon guidance receptors and ligands in blood vessel development and tumor angiogenesis. , 2005, Cytokine & growth factor reviews.

[108]  F. López-Muñoz,et al.  History of the discovery and clinical introduction of chlorpromazine. , 2005, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[109]  L. Larue,et al.  Mitf cooperates with Rb1 and activates p21Cip1 expression to regulate cell cycle progression , 2005, Nature.

[110]  J. Moreau,et al.  RLIP mediates downstream signalling from RalB to the actin cytoskeleton during Xenopus early development , 2004, Mechanisms of Development.

[111]  T. Golub,et al.  Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. , 2004, Cancer cell.

[112]  Suzie Chen,et al.  Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development , 2004, Journal of Molecular Medicine.

[113]  Andreas Bender,et al.  Similarity Searching of Chemical Databases Using Atom Environment Descriptors (MOLPRINT 2D): Evaluation of Performance , 2004, J. Chem. Inf. Model..

[114]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[115]  Richard Morphy,et al.  From magic bullets to designed multiple ligands. , 2004, Drug discovery today.

[116]  J. D. Dal Porto,et al.  B cell antigen receptor signaling 101. , 2004, Molecular immunology.

[117]  B. Roth,et al.  Magic shotguns versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia , 2004, Nature Reviews Drug Discovery.

[118]  Sergei Egorov,et al.  Pathway studio - the analysis and navigation of molecular networks , 2003, Bioinform..

[119]  J. Radich,et al.  The role of FLT3 in haematopoietic malignancies , 2003, Nature Reviews Cancer.

[120]  I. Dozmorov,et al.  Decreased glycogen synthase kinase 3‐beta levels and related physiological changes in Bacillus anthracis lethal toxin‐treated macrophages , 2003, Cellular microbiology.

[121]  Dragos Horvath,et al.  Predicting ADME properties and side effects: the BioPrint approach. , 2003, Current opinion in drug discovery & development.

[122]  J. Lehár,et al.  Systematic discovery of multicomponent therapeutics , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[123]  Barry J. Dickson Molecular Mechanisms of Axon Guidance , 2002, Science.

[124]  N. Gough Science's Signal Transduction Knowledge Environment , 2002 .

[125]  A. Paller,et al.  Incontinentia pigmenti: a review and update on the molecular basis of pathophysiology. , 2002, Journal of the American Academy of Dermatology.

[126]  J. Fryns,et al.  PTPN11 mutations in LEOPARD syndrome , 2002, Journal of medical genetics.

[127]  M. Schartl,et al.  Activation of p59Fyn Leads to Melanocyte Dedifferentiation by Influencing MKP-1-regulated Mitogen-activated Protein Kinase Signaling* , 2002, The Journal of Biological Chemistry.

[128]  K. Varani,et al.  Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line , 2001, British journal of pharmacology.

[129]  G. Ryffel,et al.  Dimerization co-factor of hepatocyte nuclear factor 1/pterin-4alpha-carbinolamine dehydratase is necessary for pigmentation in Xenopus and overexpressed in primary human melanoma lesions. , 2001, The American journal of pathology.

[130]  C. Betsholtz,et al.  Developmental roles of platelet‐derived growth factors , 2001, BioEssays : news and reviews in molecular, cellular and developmental biology.

[131]  R. Fujii The regulation of motile activity in fish chromatophores. , 2000, Pigment cell research.

[132]  B. Roth,et al.  The Multiplicity of Serotonin Receptors: Uselessly Diverse Molecules or an Embarrassment of Riches? , 2000 .

[133]  R. Buscà,et al.  Cyclic AMP a key messenger in the regulation of skin pigmentation. , 2000, Pigment cell research.

[134]  J. Drews Drug discovery: a historical perspective. , 2000, Science.

[135]  I. Dominguez,et al.  Dorsal downregulation of GSK3beta by a non-Wnt-like mechanism is an early molecular consequence of cortical rotation in early Xenopus embryos. , 2000, Development.

[136]  B. Dickson,et al.  Analysis of Drosophila photoreceptor axon guidance in eye-specific mosaics. , 2000, Development.

[137]  I. Toda,et al.  Identification of androgen receptor protein and 5α-reductase mRNA in human ocular tissues , 2000, The British journal of ophthalmology.

[138]  Stephen L. Johnson,et al.  Zebrafish sparse corresponds to an orthologue of c-kit and is required for the morphogenesis of a subpopulation of melanocytes, but is not essential for hematopoiesis or primordial germ cell development. , 1999, Development.

[139]  M. Nash,et al.  Serotonin-2A Receptor mRNA Expression in Rat Retinal Pigment Epithelial Cells , 1998, Ophthalmic Research.

[140]  Michael S. Deiner,et al.  Netrin-1 and DCC Mediate Axon Guidance Locally at the Optic Disc: Loss of Function Leads to Optic Nerve Hypoplasia , 1997, Neuron.

[141]  Philippe Soriano The PDGF alpha receptor is required for neural crest cell development and for normal patterning of the somites. , 1997, Development.

[142]  J. Wood,et al.  Protein kinase C activation by serotonin potentiates agonist-induced stimulation of cAMP production in cultured rat retinal pigment epithelial cells. , 1997, Experimental eye research.

[143]  B. Neel,et al.  Specific modulation of ectodermal cell fates in Xenopus embryos by glycogen synthase kinase. , 1995, Development.

[144]  J. Smith,et al.  Carbonic anhydrase type II in regenerating retinal pigment epithelium. A histochemical study in the rabbit , 1993, Experientia.

[145]  D. Sugden,et al.  Protein kinase C activation antagonizes melatonin-induced pigment aggregation in Xenopus laevis melanophores , 1992, The Journal of cell biology.

[146]  R. Spritz,et al.  Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[147]  R. Andersson,et al.  Characterization of pigment aggregating α2‐adrenoceptors of fish melanophores by use of different agonists after partial irreversible receptor inactivation , 1989, British journal of pharmacology.

[148]  Philippe Vayer,et al.  Toward in silico structure-based ADMET prediction in drug discovery. , 2012, Drug discovery today.

[149]  Adam E. Hendry,et al.  Chemical genetics and drug discovery in Xenopus. , 2012, Methods in molecular biology.

[150]  P. Ertl,et al.  Computational analysis of structure-activity relationships. , 2010, Progress in medicinal chemistry.

[151]  Yanli Wang,et al.  PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .

[152]  M. Panicker,et al.  Serotonin 2A (5-HT2A) Receptor Function: Ligand-Dependent Mechanisms and Pathways , 2007 .

[153]  Thorsten Meinl,et al.  KNIME: The Konstanz Information Miner , 2007, GfKl.

[154]  J. Mestres,et al.  Connecting small molecules to nuclear receptor pathways. , 2007, Current topics in medicinal chemistry.

[155]  Sean Ekins,et al.  Pathway mapping tools for analysis of high content data. , 2007, Methods in molecular biology.

[156]  Meir Glick,et al.  Enrichment of High-Throughput Screening Data with Increasing Levels of Noise Using Support Vector Machines, Recursive Partitioning, and Laplacian-Modified Naive Bayesian Classifiers , 2006, J. Chem. Inf. Model..

[157]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..

[158]  N. Rahimi,et al.  Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. , 1999, Investigative ophthalmology & visual science.

[159]  Alberto Maria Segre,et al.  Programs for Machine Learning , 1994 .

[160]  H. Shichi,et al.  Regional distribution of lipoxygenase activities in porcine ciliary epithelium. , 1991, Journal of ocular pharmacology.